Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) clinical trials
Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) is the lead sponsor of 3 current clinical trials in our Spain and France registers. 3 are recruiting patients now. The most common phase is Phase 1. The drugs named most often in its trials are Sotorasib. The most-studied condition is Pancreatic Adenocarcinoma.
ClinicalTrials.gov trials by status
Trials by phase
Clinical trials sponsored by Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)
3 on ClinicalTrials.gov| Study | Phase | Status | Start | Registers |
|---|---|---|---|---|
|
Study to Evaluate the Efficacy and Safety of Cetuximab in Combination with Encorafenib Plus Binimetinib As Induction Treatment in BRAF V600E Mutated MSS Initially Resectable or Potentially Resectable Advanced Colorectal Cancer
NCT06207656 · ClinicalTrials.gov ↗ · Colorectal Cancer
|
Phase 2 | Recruiting | 2024-04 | Spain |
|
Spanish Registry of Digestive Tumours RETUD
NCT06711211 · ClinicalTrials.gov ↗ · Digestive Cancers, Bile Duct Cancer, Hepatocellular Cancer (HCC)
|
Observational | Recruiting | 2020-12 | Spain |
|
Sotorasib Combined With First-line Chemotherapy for Advanced Pancreatic Adenocarcinoma
NCT06892054 · ClinicalTrials.gov ↗ · Pancreatic Adenocarcinoma
Drug: Sotorasib |
Phase 1 | Recruiting | 2025-08 | France, Spain |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.
Drugs in Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) trials
1 compoundDrugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.
Conditions in Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) trials
6 conditionsBy trial register
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in Spain | 3 | 3 |
| Clinical trials in France | 1 | 1 |
A trial with sites in more than one country appears in each of those registers.
Other sponsors in Pancreatic Adenocarcinoma
| Sponsor | Trials |
|---|---|
| Alpha Tau Medical | 4 |
| Diakonos Oncology Corporation | 1 |
| Liu Huang | 1 |
| Kochi University | 1 |
Sponsors with the most current trials registered for this condition.
Questions about Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) trials
How many clinical trials does Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) sponsor?
Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) is the lead sponsor of 3 current trials on ClinicalTrials.gov in our Spain and France registers, as of the registry sync on 18 November 2026. Completed and withdrawn studies are not counted.
Are Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) trials recruiting?
Yes. 3 of its 3 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Which drugs is Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) testing?
Its current trials name 1 drug or biological as interventions. The most frequent are Sotorasib (1). The number in brackets is how many of its trials name each drug.
Where does this information come from?
Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.
How this page is built
Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.
- ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, lead sponsor, phase, overall status, start date, conditions and intervention names
- EU Clinical Trials Information System (CTIS) ↗ EU trial numbers, titles, sponsor, phase, status, therapeutic area and member-state countries
This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 18 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.